Research Project
Grant-in-Aid for Scientific Research (C)
We investigated the characteristics of hypoxia-adapted MM (HA-MM) cells. Irradiated NOD/SCID mice were inoculated with AMO-1 MM cells. After 2 or 4 weeks transplantation, the inoculated MM cells were positive for pimonidazole. These observations suggested that MM cells are hypoxic in the BM. We then established HA-MM cell lines that can continue to proliferate in hypoxic conditions (1% O2) for more than six months. The G0 fraction cells significantly increased in HA-MM cells compared with those in the parental MM cells. The survival durations of mice transplanted with HA-MM cells were significantly shorter than that of mice transplanted with parental MM cells. Stem cell markers such as Sox2, Oct3, and Nanog mRNA transcripts increased in the HA-MM AMO-1 cells. Furthermore, phosphorylated Smad2 expression was increased in HA-AMO-1 cells. These findings suggest that HA-MM cells possess stem cell-like characters and may provide a useful model to investigate the mechanism of MM stem cells.
All 2013 2012 2011 Other
All Journal Article (29 results) (of which Peer Reviewed: 28 results, Open Access: 1 results) Presentation (47 results) Book (8 results) Remarks (2 results) Patent(Industrial Property Rights) (2 results) (of which Overseas: 2 results)
J Immunol
Volume: 191 Issue: 3 Pages: 1073-1081
10.4049/jimmunol.1203535
Chem Commun
Volume: 49 Issue: 27 Pages: 2801-2803
10.1039/c3cc39205h
PLoS One
Volume: 8 Issue: 1 Pages: e54862-e54862
10.1371/journal.pone.0054862
120005242481
Leukemia
Volume: 27 Issue: 3 Pages: 619-628
10.1038/leu.2012.258
120005466670
Oncol Rep
Volume: 29 Issue: 3 Pages: 941-945
10.3892/or.2012.2195
Int J Oncol
Volume: 42 Issue: 2 Pages: 525-534
10.3892/ijo.2012.1735
Journal of Neuroscience Research
Volume: 91 Issue: 1 Pages: 62-72
10.1002/jnr.23128
医療薬学
Volume: 39 Pages: 565-570
Cell Physiol Biochem
Volume: 30 Issue: 5 Pages: 1241-1253
10.1159/000343315
Volume: 198 Issue: 9 Pages: 4546-4555
10.4049/jimmunol.1103007
Volume: 28 Issue: 2 Pages: 481-486
10.3892/or.2012.1816
Curr Pharm Des
Volume: 18 Pages: 1414-1420
Blood Cancer J
Volume: 1 Issue: 6 Pages: 903-909
10.1038/bjc.2011.41
Expert Opinion on Therapeutic Targets
Volume: 15 Issue: 7 Pages: 873-887
10.1517/14728222.2011.577418
Proc Natl Acad Sci U S A
Volume: 108 Issue: 42 Pages: 17468-17473
10.1073/pnas.1111138108
Cancer Letter
Volume: 312(2) Issue: 2 Pages: 228-34
10.1016/j.canlet.2011.08.009
Volume: 312(1) Issue: 1 Pages: 91-100
10.1016/j.canlet.2011.08.002
Oncogene
Volume: 30 Issue: 24 Pages: 2789-2797
10.1038/onc.2011.3
Cancer Sci
Volume: 102 Issue: 3 Pages: 591-6
10.1111/j.1349-7006.2010.01813.x
10029291246
Eur J Immunol
Volume: 41 Issue: 1 Pages: 67-75
10.1002/eji.200939931
Volume: 15 Pages: 873-87
Proc Natl Acad Sci USA
Volume: 108 Pages: 17468-73
Cancer Lett
Volume: 312 Pages: 228-34
Volume: 312 Pages: 91-100
Volume: 102 Pages: 591-6
Volume: 39 Pages: 67-75
J Clin Bioinformatics
Volume: 1 Pages: 6-6
Antisense
Volume: 15 Pages: 31-47
Stem Cells
Volume: (in press)
http://labo.kyoto-phu.ac.jp/seiri/seiri-j.html
http://www.kyoto-phu.ac.jp/labo/seiri/seiri-j.html